EnWave Corporation and Aridis Pharmaceuticals Sign Collaboration Agreement-Relationship Expanded to Include Antibodies

VANCOUVER, BRITISH COLUMBIA and SAN JOSE, CALIFORNIA--(Marketwire - July 11, 2007) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") announces that it has reached a definitive agreement to collaborate with Aridis Pharmaceuticals, LLC ("Aridis") of San Jose, California, to determine the feasibility of EnWave's proprietary bioREV radiant energy vacuum technology to stabilize and dehydrate vaccines and antibodies.